Board of Directors
Gordon Sato, PhD | Co-Founder & Chairman of the Board, A&G Pharmaceutical
Lars Hanan, MBA | Co-Founder and Managing Partner, BroadOak Capital Partners
Tom Hancock | Principal, New England Partners/Nexus Medical Partners Fund
Prior to joining New England Partners, Mr. Hancock was a Senior Analyst and Managing Director at U.S. Bancorp Piper Jaffray, with responsibility for biopharmaceuticals and drug discovery tools. His previous positions include biotechnology analyst at NationsBanc Montgomery, founding executive at COR Therapeutics, Inc., and various laboratory research and business development positions at Genentech, Inc. Mr. Hancock received an MBA as well as a BS in Molecular Biology, both from the University of California, Berkeley.
SeungSuh “Stanley” Hong, PhD | Vice President of Business Development, Celltrion
Jennie Mather, PhD | Senior Vice President, Stem Cell Research, MacroGenics
Ginette Serrero, PhD | Co-Founder and CEO
Seung Il-Shin, PhD | Founder, Celltrion